An on-the-spot, low-cost diagnostic test for leptospirosis (Weil's disease), a bacterial infection recognised as a neglected disease by the World Health Organization, could save lives in developing countries where there is little or no access to medical pathology laboratories and specialist technicians.
Major epidemics such as the recent Ebola outbreak or the emerging Zika epidemic may be difficult to forecast because of our inability to determine whether individuals are uninfected or infected but not showing symptoms, according to a new study from the University of Cambridge. The finding emphasises the need to develop and deploy reliable diagnostic tests to detect infected individuals whether or not they are showing symptoms, say the researchers.
A non-invasive, low cost blood test that could help doctors diagnose some types of malignant childhood tumour has been developed by researchers at the University of Cambridge and Addenbrooke’s Hospital, Cambridge University Health NHS Foundation Trust.
A ‘pill on a string’ developed by researchers at the University of Cambridge could help doctors detect oesophageal cancer – cancer of the gullet – at an early stage, helping them overcome the problem of wide variation between biopsies, suggests research published today in the journal Nature Genetics.
The University of Cambridge has been awarded £2 million from the UK Medical Research Council and the Government of India’s Department for Biotechnology to develop a partnership with the National Institute for Research in Tuberculosis (NIRT) in Chennai.
A new transformative point-of-care diagnostic which gives instant results for the detection of genetic material from the HIV virus is being rolled out across Africa. The small, highly portable machine - known as SAMBA II - will help transform the lives of millions, especially HIV exposed infants who have a one in two chance of early death if HIV infection is not diagnosed within the first six weeks of life and if they are not immediately initiated on treatment.